Surface Ligand-Controlled Wavelength-Tunable Luminescence of Gold Nanoclusters: Cellular Imaging and Smart Fluorescent Probes for Amyloid Detection

Abstract

Gold nanoclusters (Au NCs) are an emerging class of fluorescent nanomaterials due to their fascinating chemical or physical properties and atomically precise structures; hence, they have been widely used in the field of biosensing and bioimaging. In this article, we demonstrate the green synthesis of orange, yellow, green, and cyan emitting Au NCs by core etching and ligand exchange methodology. Our investigation reveals that the chain length of the mercaptan acids, which are present on the surface of the Au NCs, controls the optical and electronic properties of the synthesized NCs. The steady-state and time-resolved spectroscopic data suggest that the emission properties of Au NCs mainly originate from the ligand to metal charge transfer (LMCT) transition. Alterations of the optical properties of these Au NCs can be proposed due to the difference in the core size of the Au NCs, which is strongly influenced by the surface-capping ligands. These NCs are highly biocompatible and nontoxic as evidenced by the cell viability and cellular uptake studies. By virtue of this, our as-synthesized NCs have been successfully used as excellent intracellular fluorescent imaging probes. Interestingly, fluorescence properties of Au NCs can efficiently probe the protein amyloids associated with several neurodegenerative diseases. To facilitate research in the field of amyloidosis, we have demonstrated fluorescence lifetime imaging microscopy (FLIM) and fluorescence correlation spectroscopy (FCS) as two advanced tools to probe the aggregation of proteins and to monitor the physical interactions between proteins and NCs. It has been observed that the hydrophobicity of the NC surface can trigger the amyloid detection capability of Au NCs. Owing to these unique optical and attractive biological properties coupled with the imaging capability, these ultrasmall-sized Au NCs may enable in vivo detection of amyloids in the near future.